Results 151 to 160 of about 2,398,416 (309)

[Texas Instruments Press Releases, June-July 1966]

open access: yes, 1966
1. Release dated June 1, 1966 is in regard to the award of a $585,954 contract for analytical support of a field test in connection with on-site inspection to identify underground nuclear tests as part of CLOUD GAP. 2.
Texas Instruments Incorporated
core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

A measurement comparability study to support instrument harmonization in the Canadian Longitudinal Study on Aging. [PDF]

open access: yesAm J Epidemiol
Rafiq T   +14 more
europepmc   +1 more source

[Texas Instruments Press Releases, June-December 1957]

open access: yes, 1957
Release dated June 12, 1957 is in regard to TI president J. Erik Jonsson's remarks to security analysts regarding the company's future for 1957. Release dated June 14, 1957 from the GSI subsidiary of TI is in regard to an orientation and training ...
Texas Instruments Incorporated
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

[Texas Instruments Press Releases, January-February 1970]

open access: yes, 1970
1. Press release dated January 2, 1970 is in regard to remarks by TI Senior VP Bryan F. Smith on electronics as a growth industry. 2. Press release dated January 6, 1970 announces a new line of low-cost phototransistors, the TIL-63 through TIL-67 devices.
Texas Instruments Incorporated
core  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy